Send feedback

CFAP20DC p.Arg295Ter

c.883C>T · VCV3390946

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
nonsense (stop-gain)
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00254%, nfe)
Conditions
1
tuberous sclerosis 2

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequencenonsense (stop-gain)predicted loss-of-function
NMDpredictedpremature termination codon in exon 9 of 17
Splicing
SpliceAI—not assessed · no allele here is in the release
PangolinΔ0.41loss · gain 0.01 · not in the SpliceAI release · independent
Constraint at this position
ConservationphyloP 4.7GERP 0.89, phastCons 1
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00254% European (non-Finnish) · 30/1,178,950 alleles
Filtering AF 0.00181% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00157%
Overall 0.00211% 34/1,611,656 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00321% 31,194
European (non-Finnish)grpmax 0.00254% 39,298
South Asian 0.00221% 45,278

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CFAP20DC
Protein
p.Arg295Ter
Coding
c.883C>T
MANE Select
NM_001394063
Type
single nucleotide variant
Location
chr3:58869460 (GRCh38)
Gene constraint
LOEUF 0.894 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 53.59
Full CFAP20DC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

tuberous sclerosis 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Tuberous sclerosis complex (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (Taiwan, Province of China)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfap20dc-p-arg295ter (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown